New Data on Ceplene® Cancer Immunotherapy to be Presented at the 2016 AACR Annual Meeting

March 17, 2016

 

Re-distribution of cytotoxic T-Cell Subsets During Therapy with Ceplene Predicts Overall Survival in Patients with Acute Myeloid Leukemia NEW YORK, March 17, 2016 /PRNewswire/ — Immune Oncology Pharmaceuticals, a clinical-stage biopharmaceutical company and a subsidiary of Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced today that new clinical pharmacology and outcomes data with Ceplene (histamine dihydrochloride) will be…

Search

RECENT PRESS RELEASES

Related Post

Farewell to hydrogen, electricity or gas: This ship runs on a 500-year-old fuel
Farewell to hydrogen, electricity or gas: This ship runs on a 500-year-old fuel
Gallery

Farewell to hydrogen, electricity or gas: This ship runs on a 500-year-old fuel

December 22, 2024|0 Comments
What Google’s quantum computing breakthrough Willow means for the future of bitcoin and other cryptos
What Google’s quantum computing breakthrough Willow means for the future of bitcoin and other cryptos
Gallery

What Google’s quantum computing breakthrough Willow means for the future of bitcoin and other cryptos

December 22, 2024|0 Comments
$0.15 ETH Rival to Pump 9404% Like Ethereum in 2017 and Reach $14 in the Next 5 Months
$0.15 ETH Rival to Pump 9404% Like Ethereum in 2017 and Reach $14 in the Next 5 Months
Gallery

$0.15 ETH Rival to Pump 9404% Like Ethereum in 2017 and Reach $14 in the Next 5 Months

December 22, 2024|0 Comments
Ethereum Set To Move Up Against Bitcoin, According to Analyst Benjamin Cowen – Here’s His Outlook
Ethereum Set To Move Up Against Bitcoin, According to Analyst Benjamin Cowen – Here’s His Outlook
Gallery

Ethereum Set To Move Up Against Bitcoin, According to Analyst Benjamin Cowen – Here’s His Outlook

December 22, 2024|0 Comments